Staff Contact: Jane Drummond
Monday, the Missouri Senate passed SB 751 on to the House for final consideration. The version passed by the Senate represents a compromise encouraged by Senate Floor Leader Cindy O’Laughlin and prohibits pharmaceutical manufacturers from restricting the number of contract pharmacies 340B entities can use. The final vote in the Senate was 28-3.
The House passed nearly identical language as part of its larger pharmacy bill (HB 2267) just two weeks ago on a vote of 113-28. SB 751 is scheduled to be heard in the House Special Committee on Special Policy on Thursday, May 2.